Literature DB >> 19807618

Health-related quality of life and symptom research in glioblastoma multiforme patients.

Martin Jb Taphoorn1, Andrew Bottomley.   

Abstract

Health-related quality of life is increasingly becoming an important end point in cancer research. Until recently, relatively little was known about the health-related quality of life of glioblastoma multiforme patients. This is due to the relative scarcity of this disease compared with other cancers and its dismal prognosis. Now, there is progress in the treatment of this tumor: new (combination) treatments will be studied in randomized trials and health-related quality will be incorporated as a (secondary) end point next to progression-free survival. Glioblastoma multiforme patient health-related quality of life may also have prognostic significance and may, therefore, be used with the individual patient to tailor treatment. This review aims to chart the history of glioblastoma multiforme and treatment, reporting on the latest health-related quality of life tools and research findings.

Entities:  

Year:  2005        PMID: 19807618     DOI: 10.1586/14737167.5.6.763

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  5 in total

1.  Overexpression of p53 delivered using recombinant NDV induces apoptosis in glioma cells by regulating the apoptotic signaling pathway.

Authors:  Xiaoyong Fan; Hongzhen Lu; Youqiang Cui; Xianzeng Hou; Chuanjiang Huang; Guangcun Liu
Journal:  Exp Ther Med       Date:  2018-03-08       Impact factor: 2.447

2.  Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.

Authors:  Erqi L Pollom; Dylann Fujimoto; Jacob Wynne; Kira Seiger; Leslie A Modlin; Lisa R Jacobs; Melissa Azoulay; Rie von Eyben; Laurie Tupper; Iris C Gibbs; Steven L Hancock; Gordon Li; Steven D Chang; John R Adler; Griffith R Harsh; Ciara Harraher; Seema Nagpal; Reena P Thomas; Lawrence D Recht; Clara Y H Choi; Scott G Soltys
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-02-07       Impact factor: 7.038

3.  Response to imatinib as a function of target kinase expression in recurrent glioblastoma.

Authors:  Marco Ronald Hassler; Mariam Vedadinejad; Birgit Flechl; Christine Haberler; Matthias Preusser; Johannes Andreas Hainfellner; Adelheid Wöhrer; Karin Ute Dieckmann; Karl Rössler; Richard Kast; Christine Marosi
Journal:  Springerplus       Date:  2014-02-25

4.  Insomnia and its associations in patients with recurrent glial neoplasms.

Authors:  Matthew E Robertson; Frances McSherry; James E Herndon; Katherine B Peters
Journal:  Springerplus       Date:  2016-06-21

5.  The phosphatase and tensin homolog gene inserted between NP and P gene of recombinant New castle disease virus oncolytic effect test to glioblastoma cell and xenograft mouse model.

Authors:  Sung Hoon Jang; Bo-Kyoung Jung; Yong Hee An; Hyun Jang
Journal:  Virol J       Date:  2022-01-29       Impact factor: 4.099

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.